Explore Stanford technologies available for licensing:

Stanford researchers at the Vuckovic Lab have developed a full chip-scale integration of a Ti:Sapphire laser system which dramatically reduces the size, cost, and power consumption by many orders of magnitude, compared to today's state-of-the-art systems which are bulky and ex

Researchers at Stanford have developed agents to enhance the therapeutic efficacy of a variety of anti-cancer therapeutics. Cell loss by apoptosis occurs in normal development and in tumor environments.

Researchers in Prof. A.C. Matin's laboratory have developed a versatile exosome (extracellular vesicle, "EV") drug delivery platform that can selectively target therapeutic agents to tumors or other tissues that overexpress extracellular receptors.

Stanford researchers have developed a rapid, accurate, and accessible method to test for food allergy and other types of allergy.

Researchers at Stanford have developed a software application solution to the spatial computing problem of aligning virtual content to the real world.

Researchers at Stanford have shown that two CRISPR-Cas nucleases, Cas9 and Cpf1, can be programmed to produce efficient RNA-guided nickases.

Disease Indication Oncology, hematological cancers, breast cancer, solid tumors

Drug Format Cell therapy

Drug Class Best-in-class

Target CD19, HER2, B7-H3, GPC2 and all other tumor antigens

Stanford researchers have developed a low cost, safe, environmentally friendly, rechargeable Zn/MnO₂ flow battery with the potential for grid scale energy storage.

Researchers in Dr. Mark Kay's lab have developed a patented approach to inducing apoptosis that could represent a new strategy against cancer and other diseases.

This bandage-like multi-lead, continuous ECG monitoring device uses new stretchable electrode material developed in the Bao group to accurately and imperceptibly diagnose cardiac arrhythmia.

Stanford researchers at the Prakash Lab have developed Octopi, a low-cost ($250-$500) and reconfigurable autonomous microscopy platform capable of automated slide scanning and correlated bright-field and fluorescence imaging.

Researchers at Stanford have developed a device capable of delivering ultrasonic neuromodulation to defined areas of the brain while simultaneously recording neuronal activity with cell-type specificity.

Stanford researchers have optimized air-core coil design for wireless power transfer and demonstrated a 2x improvement over current designs. Existing resonant tank and coils are restraining MHz frequency inductive wireless power transfer efficiency.

Researchers at Stanford have developed a novel therapeutic approach for dilated cardiomyopathy (DCM). DCM is characterized by left ventricular enlargement and reduced systolic function.

Researchers in Dr. Holden Maecker's lab have developed platinum-labeled probes to expand the analytical capacity of mass cytometry instruments. Currently, analytical capacity is limited by the ability to label specific probes with appropriate metal ions.